Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation
- 1 June 1998
- journal article
- Published by Elsevier in Neuroscience
- Vol. 86 (4) , 1121-1132
- https://doi.org/10.1016/s0306-4522(98)00163-8
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Structural, neurochemical and behavioural consequences of neonatal blockade of NMDA receptor through chronic treatment with CGP 39551 or MK-801Published by Elsevier ,2003
- Noncompetitive NMDA Receptor Antagonists with Fast Open-Channel Blocking Kinetics and Strong Voltage-Dependency as Potential Therapeutic Agents for Alzheimer's DementiaPharmacopsychiatry, 1995
- Delayed administration of memantine prevents N‐methyl‐D‐aspartate receptor‐mediated neurotoxicityAnnals of Neurology, 1993
- Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats.Stroke, 1993
- A rat model of severe neonatal hypoxic-ischemic brain injury.Stroke, 1992
- NMDA Antagonist Neurotoxicity: Mechanism and PreventionScience, 1991
- Comparative Effect of Transient Global Ischemia on Extracellular Levels of Glutamate, Glycine, and γ‐Aminobutyric Acid in Vulnerable and Nonvulnerable Brain Regions in the RatJournal of Neurochemistry, 1991
- Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain studyEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989
- Wirkungen oraler Memantin-Gaben auf die Parkinson-Symptomatik: Ergebnisse einer placebo-kontrollierten Multicenter-StudieDeutsche Medizinische Wochenschrift (1946), 1984